Radiosensitisation of Hepatocellular Carcinoma Cells by Vandetanib.
Sami A ZnatiRebecca CarterMarcos VasquezAdam WesthorpeHassan ShahbakhtiJessica PrincePetra VlckovaChiara De VellisZainab A BascalMarilena LoizidouRicky A SharmaPublished in: Cancers (2020)
In 2D and 3D studies in vitro and in a syngeneic model in vivo, the combination of vandetanib plus radiotherapy was more efficacious than either treatment alone. This new combination therapy for HCC merits evaluation in clinical trials.